ArticleJournal of inorganic biochemistry2026
Cu(I) and Cu(II) binding by hyperactive variants of the human CTR1 N-terminus: Insights from cellular and model peptide studies.
Article in Journal of inorganic biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Copper (Cu) trafficking requires precise control of Cu(II)/Cu(I) redox chemistry to enable cellular acquisition while preventing toxicity. Human Cu transporter 1 protein (hCTR1) mediates cellular Cu uptake, yet key molecular details governing its extracellular Cu acquisition remain unresolved. Although hCTR1 is a Cu(I)-selective pore, extracellular Cu may be presented by carriers in the Cu(II) oxidation state. The N-terminal ectodomain of hCTR1 contains adjacent high-affinity Cu(II) and Cu(I)-binding sites that are proposed to facilitate Cu(II) reduction prior to transport. To investigate the role of residues in mediating Cu uptake, we combined cellular screening for hCtr1 mutations that confer enhanced Cu uptake phenotypes with spectroscopic studies of model peptides. We identified four site-specific substitutions within the distal ectodomain (D2N, M7T, G8E, and M9T) that increase cellular Cu uptake. Using model peptides corresponding to the first 14 residues of hCTR1 (hCTR
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.